BiotechTube
Home/Lutris Pharma/Sumant Ramachandra, M.D., Ph.D., MBA
SR

Sumant Ramachandra, M.D., Ph.D., MBA

Chief Executive Officer and Board Director

Lutris Pharma

Therapeutic Areas

Oncology

Lutris Pharma Pipeline

DrugIndicationPhase
LUT014EGFR inhibitor‑induced acneiform lesions in metastatic colorectal cancerPhase 2

Leadership Team at Lutris Pharma

JP
John Paul Waymack, M.D., Sc.D.
Director, Regulatory Affairs
CJ
Colleen Johnson, M.S, DABT
Director, Pre‑Clinical Development
LM
Laura Millichamp, Ph.D.
Director, Chemistry Manufacturing Control
View full Lutris Pharma profile